Showing 1 of 1 recruiting trials for “Pitt-Hopkins syndrome”
Phase 1/2 Study of MZ-1866, an AAV-9 Gene Therapy Delivered by Intracerebroventricular Injection to Participants With Pitt Hopkins Syndrome
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →